SCHEMBL901598

SCHEMBL901598

O=C(O)c1c(O)c(O)c2ccccc2c1C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.48
HPGD P15428 3/20 0.48
CYP2C9 P11712 2/20 0.48
THRB P10828 1/20 0.48
TSHR P16473 1/20 0.48
ALOX12 P18054 1/20 0.48
ATIC P31939 1/20 0.48
KDM4E B2RXH2 4/20 0.48
MEN1 O00255 2/20 0.48
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP1A2 P05177 1/20 0.48
GLA P06280 1/20 0.48
CYP2C19 P33261 1/20 0.48
DHODH Q02127 3/20 0.46
PDE10A Q9Y233 2/20 0.46
MAPT P10636 1/20 0.46
PKM P14618 1/20 0.46
HTT P42858 1/20 0.46
TDP1 Q9NUW8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31039922 0.91 DHODH (0.50) HSD17B10HPGDCYP2C9THRBTSHR
SCHEMBL6450325 0.91 DHODH (0.50) HSD17B10HPGDCYP2C9THRBTSHR
SCHEMBL27572021 0.91 HSD17B10 (0.48) HSD17B10HPGDCYP2C9THRBTSHR
SCHEMBL7537511 0.88 DHODH (0.52) HSD17B10HPGDCYP2C9THRBTSHR
SCHEMBL344711 0.88 HSD17B10 (0.50) HSD17B10HPGDCYP2C9THRBTSHR
SCHEMBL29260803 0.88 DHODH (0.55) HSD17B10HPGDCYP2C9THRBTSHR
SCHEMBL31414101 0.88 HSD17B10 (0.54) HSD17B10HPGDCYP2C9THRBTSHR
SCHEMBL4415520 0.88 HSD17B10 (0.54) HSD17B10HPGDCYP2C9THRBTSHR
SCHEMBL2477681 0.86 HSD17B10 (0.58) HSD17B10HPGDCYP2C9THRBTSHR
SCHEMBL28261469 0.84 DHODH (0.52) HSD17B10HPGDCYP2C9THRBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-11279278-A None JP disclosed
CN-119365507-A Polyurethane foam 井上株式会社 2025-01-24 CN disclosed
CN-119256030-A Polyurethane foam 井上株式会社 2025-01-03 CN disclosed
US-20240254317-A1 DOPANT SOLUTION FOR CONDUCTIVE POLYMER, MONOMER LIQUID FOR PRODUCING CONDUCTIVE POLYMER, CONDUCTIVE COMPOSITION AND METHOD FOR PRODUCING SAME, AND ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING SAME TAYCA CORPORATION (JP) 2024-08-01 US disclosed
WO-2023248536-A1 POLYURETHANE FOAM 株式会社イノアックコーポレーション 2023-12-28 WO disclosed
WO-2023248535-A1 POLYURETHANE FOAM 株式会社イノアックコーポレーション 2023-12-28 WO disclosed
US-11600449-B2 Layer compositions with improved electrical parameters comprising PEDOT/PSS and a stabilizer HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2023-03-07 US disclosed
EP-3419033-B1 A SOLID POLYMER CAPACITOR HAVING IMPROVED ELECTRICAL PARAMETERS AT LOW TEMPERATURE HERAEUS DEUTSCHLAND GMBH & CO KG (DE) 2023-02-01 EP disclosed
WO-2022255209-A1 DOPANT SOLUTION FOR CONDUCTIVE POLYMER, MONOMER SOLUTION FOR PRODUCING CONDUCTIVE POLYMER, CONDUCTIVE COMPOSITION AND METHOD FOR PRODUCING SAME, AND ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING SAME テイカ株式会社 2022-12-08 WO disclosed
US-10336859-B2 Method for preparing an electrolyte capacitor TAYCA CORPORATION (JP) 2019-07-02 US disclosed
US-9508491-B2 Method for improving electrical parameters in capacitors comprising PEDOT/PSS as a solid electrolyte through a polyalkylene glycol Heraeus Deutschland GmbH & Co. KG (DE) 2016-11-29 US disclosed
US-20160220454-A1 Compound, Composition, Polymer, Mylar Film and Method for Indicating Maximum Exposure to the Sun and UV Radiation GENESIS LABORATORIES INC (DE) 2016-08-04 US disclosed
US-20140334066-A1 SOLID ELECTROLYTE CAPACITOR AND A METHOD FOR MANUFACTURING THE SAME TAYCA CORPORATION (JP) 2014-11-13 US disclosed
US-20130279079-A1 METHOD FOR IMPROVING ELECTRICAL PARAMETERS IN CAPACITORS COMPRISING PEDOT/PSS AS A SOLID ELECTROLYTE THROUGH A POLYALKYLENE GLYCOL HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2013-10-24 US disclosed
EP-2622018-A1 LAYER COMPOSITIONS WITH IMPROVED ELECTRICAL PARAMETERS COMPRISING PEDOT/PSS AND A STABILIZER Heraeus Precious Metals GmbH & Co. KG (DE) 2013-08-07 EP disclosed
WO-2012041507-A1 LAYER COMPOSITIONS WITH IMPROVED ELECTRICAL PARAMETERS COMPRISING PEDOT/PSS AND A STABILIZER HERAEUS PRECIOUS METALS GMBH & CO. KG (DE) 2012-04-05 WO disclosed
JP-H11279278-A AROMATIC POLYAMIDE AND ITS PRODUCTION SUGAI CHEM IND CO LTD 1999-10-12 JP disclosed
EP-0320227-B1 Method of preventing polymer-scale formation SHINETSU CHEMICAL CO (JP) 1994-09-07 EP disclosed
US-4933399-A COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 1990-06-12 US disclosed
EP-0320227-A2 Method of preventing polymer-scale formation Shin-Etsu Chemical Co., Ltd. (JP) 1989-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240254317-A1 DOPANT SOLUTION FOR CONDUCTIVE POLYMER, MONOMER LIQUID FOR PRODUCING CONDUCTIVE POLYMER, CONDUCTIVE COMPOSITION AND METHOD FOR PRODUCING SAME, AND ELECTROLYTIC CAPACITOR AND METHOD FOR PRODUCING SAME ADCY10, ADCY1, ADH1A HSD17B10 531/4885HPGD 592/4885CYP2C9 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.